← Back to Search

Art Therapy for High-Risk Pregnancies

N/A

Waitlist Available

Led By Sara N Iqbal, MD

Research Sponsored by Medstar Health Research Institute

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up up to 3 months postpartum

Awards & highlights

Study Summary

This trial will study whether art therapy can help reduce postpartum depression and improve mother-baby bonding in high-risk pregnancies.

Who is the study for?

This trial is for women over 18 with high-risk pregnancies in their second trimester, who speak English and have internet access. They must plan to give birth at Washington Hospital Center. Women not meeting these conditions are excluded.Check my eligibility

What is being tested?

The study explores the effects of art therapy on postpartum depression and bonding between mother and baby in high-risk pregnant women, comparing it to no intervention.See study design

What are the potential side effects?

Since this trial involves art therapy, there are no direct medical side effects; however, emotional or psychological responses may vary among participants.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ start, and end of intervention period; time of delivery, two weeks postpartum, six weeks postpartum, three months postpartum

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~start, and end of intervention period; time of delivery, two weeks postpartum, six weeks postpartum, three months postpartum

This trial's timeline: 3 weeks for screening, Varies for treatment, and start, and end of intervention period; time of delivery, two weeks postpartum, six weeks postpartum, three months postpartum for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

change in maternal-infant bonding scores

changes in Edinburgh Postnatal Depression Scale scores

use of psychiatry medications during and after pregnancy

+1 more

Secondary outcome measures

APGAR scores

NICU admissions

birth weight

+5 more

Trial Design

2Treatment groups

Experimental Treatment

Placebo Group

Group I: InterventionExperimental Treatment1 Intervention

Engage in six art therapy sessions

Group II: ControlPlacebo Group1 Intervention

Engage in usual activities

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

Medstar Health Research InstituteLead Sponsor

189 Previous Clinical Trials

115,477 Total Patients Enrolled

Sara N Iqbal, MDPrincipal InvestigatorMedstar

Media Library

Art Therapy Clinical Trial Eligibility Overview. Trial Name: NCT05503056 — N/A

Depression Research Study Groups: Intervention, Control

Depression Clinical Trial 2023: Art Therapy Highlights & Side Effects. Trial Name: NCT05503056 — N/A

Art Therapy 2023 Treatment Timeline for Medical Study. Trial Name: NCT05503056 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

What are the anticipated results of this research?

"Over a 1 year to 16 month period, this research endeavour aims to measure changes in Edinburgh Postnatal Depression Scale scores of participants. Additional objectives include chart reviews for obstetrical complications (postpartum hemorrhage, OASIS and ICU admission), reason for delivery (iatrogenic vs spontaneous) and APGAR scores."

Answered by AI

Is this study in the process of seeking participants?

"Confirmed, this clinical trial is recruiting patients as reported on the official website. It was initially posted on September 1st 2022 and its details were most recently updated on September 15th of that same year."

Answered by AI

How many participants are included in this research endeavor?

"Affirmative. According to the information on clinicaltrials.gov, this medical experiment is currently accepting participants. It was initially publicized on September 1st 2022 and last modified on the 15th of that same month. The trial seeks 100 subjects from a single site."

Answered by AI